Abstract:Objective To investigate the effects of lamotrigine combined with vitamin B12 on amino acid metabolism and electroencephalogram (EEG) parameters in children with cerebral palsy complicated by epilepsy.Methods A total of 83 children with cerebral palsy and epilepsy were retrospectively enrolled and divided into a control group (lamotrigine treatment, n = 41) and a combination group (lamotrigine combined with vitamin B12 treatment, n = 42). EEG parameters (relative power of δ, θ, α, and β waves), cognitive function (assessed using the Wechsler Intelligence Scale for Children-Chinese Revised, WISC-CR, including full-scale intelligence quotient [FIQ], verbal intelligence quotient [VIQ], and performance intelligence quotient [PIQ] ), amino acid metabolism indices (aspartic acid [Asp], glutamic acid [Glu], glycine [Gly] ), serum inflammatory cytokines (IL-6, IL-1β, TNF-α), and incidence of adverse reactions were analyzed before and after treatment.Results The combination group demonstrated significantly greater reductions in θ wave activity compared to the control group (P < 0.05). More pronounced improvements were observed in full-scale IQ (FIQ), verbal IQ (VIQ), and performance IQ (PIQ) scores in the combination group versus controls (P < 0.05). Significant between-group differences were noted in the changes of aspartic acid (Asp), glutamic acid (Glu), and glycine (Gly) levels (P < 0.05). The combination group showed greater reductions in IL-6, IL-1β, and TNF-α levels than the control group (P < 0.05). No statistically significant difference was found in total adverse event incidence between groups (P > 0.05).Conclusion The combination of lamotrigine and vitamin B12 effectively improves amino acid metabolic balance, reduces inflammatory cytokine levels, and enhances cognitive function in children with cerebral palsy complicated by epilepsy.